Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 0409-8183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 0409-8183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Potassium 01)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
This is a description of a single-dose Reonly Acetate injection containing 40 mEq/20 mL of potassium acetate. It is adjusted to a pH of 6.2 and is meant for intravenous use only. It should be diluted before use and any unused portion should be discarded. The product is sterile and contains no more than 200meg/L of aluminum. The distributor is Hospira, Inc. The text also contains a product code, NDC 0409-8183-15, and additional technical information such as osmolality and pH level.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
The text is a set of instructions for using a solution containing potassium acetate. The solution should be added to a suitable renal solution, and may contain acetic acid for pH adjustment. The solution is non-pyrogenic and should only be used if the seal is intact and undamaged. Any unused portion should be discarded promptly. Additionally, the set of instructions includes a product code: SN 51009150241.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.